Other OTC - Delayed Quote USD

Novozymes A/S (NVZMY)

54.98 -0.68 (-1.22%)
As of 9:30 AM EDT. Market Open.
Loading Chart for NVZMY
DELL
  • Previous Close 55.66
  • Open 54.98
  • Bid --
  • Ask --
  • Day's Range 54.98 - 54.98
  • 52 Week Range 38.75 - 61.86
  • Volume 18
  • Avg. Volume 18,819
  • Market Cap (intraday) 25.53B
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) 35.47
  • EPS (TTM) 1.55
  • Earnings Date --
  • Forward Dividend & Yield 0.88 (1.59%)
  • Ex-Dividend Date May 1, 2024
  • 1y Target Est 68.70

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

www.novozymes.com

6,397

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NVZMY

Performance Overview: NVZMY

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NVZMY
0.13%
OMX Copenhagen 25 Index
2.62%

1-Year Return

NVZMY
2.02%
OMX Copenhagen 25 Index
1.53%

3-Year Return

NVZMY
15.55%
OMX Copenhagen 25 Index
6.09%

5-Year Return

NVZMY
28.37%
OMX Copenhagen 25 Index
63.49%

Compare To: NVZMY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NVZMY

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    25.84B

  • Enterprise Value

    26.79B

  • Trailing P/E

    35.83

  • Forward P/E

    25.06

  • PEG Ratio (5yr expected)

    1.09

  • Price/Sales (ttm)

    6.05

  • Price/Book (mrq)

    12.95

  • Enterprise Value/Revenue

    1.50

  • Enterprise Value/EBITDA

    4.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.90%

  • Return on Assets (ttm)

    9.90%

  • Return on Equity (ttm)

    21.27%

  • Revenue (ttm)

    17.9B

  • Net Income Avi to Common (ttm)

    3.02B

  • Diluted EPS (ttm)

    1.55

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.12B

  • Total Debt/Equity (mrq)

    54.22%

  • Levered Free Cash Flow (ttm)

    2.14B

Research Analysis: NVZMY

Analyst Price Targets

67.20
68.70 Average
54.98 Current
70.20 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: NVZMY

People Also Watch